In this context, Yang et al., in an attempt to suggest OPG as a noninvasive biomarker for NASH diagnosis and NAFLD progression, found that serum OPG was lower in NASH patients compared to normal controls (54). The gene discussed is TNFRSF11B; the disease is metabolic dysfunction-associated steatotic liver disease.